Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Laboratories Inc.

www.abbott.com

Latest From Abbott Laboratories Inc.

Abbott’s Machine Learning Algorithm Predicts Risk Of Heart Attacks In Trial

Results of a study in over 11,000 patients shows Abbott’s MI3 algorithm can risk-stratify patients with suspected myocardial infarction and help doctors decide which patients are most likely to benefit from earlier clinical decisions.

Clinical Trials Artificial Intelligence

Public Citizen Strikes Out In Call For Opioid Approval Moratorium After Recent Win

Petition was consumer advocacy group's first request for halt to approval of an entire drug class; Public Citizen has gotten full and partial approval of other recent petitions.

Drug Approval Standards FDA

Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users

ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.

Exec Chat Digital Health

Wellness Market Executive Decisions: Beckham For Pedialyte, 'Gronk' For CBD, Honderd Out At Mary's, Appointments At GB Sciences, Nature's Bounty

Cleveland Browns' Beckham promotes Pedialyte for all; Pfizer consumer execTahiri heads Nature 's Bounty international business;GB Sciences adds cannabis operations expert; Honderd steps away at Mary's Brands; and 'Gronk' invests in CBD product firm, begins product development.

Dietary Supplements Appointments
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register